Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by MannKind
< Previous
1
2
Next >
MannKind to Present at Upcoming Investor Conferences
August 27, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
August 27, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
August 25, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
SCPH
MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement
August 06, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update
August 06, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025
July 30, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23
June 09, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind to Present at Upcoming Investor Conferences
May 13, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update
May 08, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025
May 01, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options
April 07, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
March 10, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 26, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025
February 19, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind to Present at Upcoming Investor Conferences
February 06, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Expands Executive Leadership Team
January 06, 2025
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Corporation Announces Exchange of Convertible Notes for Stock and Cash
December 18, 2024
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®)
December 16, 2024
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
CDSCO Approves Afrezza® (insulin human) Inhalation Powder in India
December 11, 2024
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update
November 07, 2024
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind to Present at 2024 UBS Healthcare Conference
November 05, 2024
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic Diseases
November 04, 2024
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024
October 31, 2024
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
More Adults With Type 1 Diabetes Achieved A1C Goal (<7%) After Switching From Multiple Daily Insulin Injections or Automated Pumps to Inhaled Insulin (Afrezza®)
September 30, 2024
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Announces Clearance from PMDA to Initiate Phase 3 Clinical Trial (ICoN-1) in Japan Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease
September 18, 2024
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind to Present at 2024 Cantor Fitzgerald Global Healthcare Conference
September 10, 2024
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind to Present at Upcoming Conferences
August 27, 2024
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
Kent Kresa to Retire from MannKind’s Board of Directors; Steven B. Binder to be Appointed to the Board
August 14, 2024
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Corporation Reports 2024 Second Quarter Financial Results: Provides Clinical Development Update
August 07, 2024
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
MannKind Launches Educational Website to Raise Awareness of NTM Lung Disease
July 31, 2024
From
MannKind
Via
GlobeNewswire
Tickers
MNKD
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.